SHARDACROP Sharda Cropchem Q2 FY26 results (Jul–Sep 2025) and concall
Sharda Cropchem reported a strong Q2 FY26 with 20% revenue growth to INR929 crores, supported by a 35% volume increase and 690 bps gross margin expansion. EBITDA surged 71% to INR139 crores, reaching a 15% margin. The company maintained a debt-free status and improved working capital, while also planning INR450-500 crores in capex for FY26 to boost product registrations. However, the non-agrochemical segment saw an 11% decline, and management's responses to questions on pricing and agrochemical EBIT variations were notably evasive.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 19.6%, net profit up 76.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 777 | 929 | 1,829 | 985 | 929 +20% |
| EBITDA | 90 | 115 | 303 | 215 | 133 +48% |
| Net profit | 42 | 31 | 204 | 143 | 74 +76% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
